001065.KS

JW Pharmaceutical Corporation [001065.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

001065.KS Stock Summary

Top 001065.KS Correlated Resources

001065.KS


Top 10 Correlated Stocks

001065.KS


In the News

001065.KS Financial details

Company Rating
Strong Buy
Market Cap
797.67B
Income
12.13B
Revenue
660.66B
Book val./share
2035.71
Cash/share
-
Dividend
400
Dividend %
1.23%
Employees
1.13K
Optionable
No
Shortable
Yes
Earnings
-
P/E
281.46
Forward P/E
-
PEG
-23.77
P/S
5.17
P/B
15.94
P/C
-
P/FCF
104.58
Quick Ratio
-
Current Ratio
1.22
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
115.29
EPS next Y
-
EPS next Q
-
EPS this Y
-98.53%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-21.28%
Revenue last 5Y
3.82%
Revenue Q/Q
2.93%
EPS Q/Q
744.09%
-
-
-
-
SMA20
-0.02%
SMA50
-9.17%
SMA100
-10.89%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
6%
ROC
0.16%
Gross Margin
40%
Oper. Margin
7%
Profit Margin
2%
Payout
347%
Shs Outstand
20.1M
Shs Float
11.41M
-
-
-
-
Target Price
-
52W Range
28900.0-39000.0
52W High
-16.79%
52W Low
+12.28%
RSI
46.14
Rel Volume
0.29
Avg Volume
341
Volume
98
Perf Week
-0.92%
Perf Month
-6.75%
Perf Quarter
-11.46%
Perf Half Y
-9.86%
-
-
-
-
Beta
0.333218
-
-
Volatility
390.45%, 1147.31%
Prev Close
0.78%
Price
32450
Change
1.41%

001065.KS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
20.68K22.09K21.03K22.51K5.78K
Net income per share
-30.53331.3-1.04K-626.72-9.23
Operating cash flow per share
1.38K2.14K2.28K2.59K172.78
Free cash flow per share
925.171.8K1.74K1.97K49.79
Cash per share
1.32K1.27K1.72K2.27K625.99
Book value per share
11.13K10.7K9.46K8.53K1.92K
Tangible book value per share
10.31K10.07K8.58K7.8K1.59K
Share holders equity per share
11.13K10.7K9.46K8.53K1.92K
Interest debt per share
8.19K7.56K8.17K7.8K2.41K
Market cap
589.93B589.12B617.78B819.29B3514.12B
Enterprise value
748.19B733.39B763.44B991.06B3725.89B
P/E ratio
-794.5573.12-24.44-53.75-3.63K
Price to sales ratio
1.171.11.211.55.79
POCF ratio
17.6411.3111.1212.99193.89
PFCF ratio
26.2213.4614.5617.06672.89
P/B Ratio
2.182.262.693.9517.47
PTB ratio
2.182.262.693.9517.47
EV to sales
1.491.371.491.816.14
Enterprise value over EBITDA
28.4320.04-281.9565.6183.81
EV to operating cash flow
22.3714.0713.7515.72205.58
EV to free cash flow
33.2516.7617.9920.64713.45
Earnings yield
00.01-0.04-0.020
Free cash flow yield
0.040.070.070.060
Debt to equity
0.050.180.140.360.61
Debt to assets
0.570.560.60.620.7
Net debt to EBITDA
6.013.94-53.811.374.76
Current ratio
1.51.641.211.281.3
Interest coverage
2.452.48-1.69-0.174.25
Income quality
-45.056.47-2.2-4.14-18.73
Dividend Yield
0.010.010.010.010
Payout ratio
-7.930.81-0.27-0.46-7.39
Sales general and administrative to revenue
0.120.120.080.120.14
Research and developement to revenue
0.040.040.050.040.03
Intangibles to total assets
0.030.030.040.030.03
Capex to operating cash flow
-0.33-0.16-0.24-0.24-0.71
Capex to revenue
-0.02-0.02-0.03-0.03-0.02
Capex to depreciation
-0.58-0.47-0.64-0.73-0.8
Stock based compensation to revenue
00000
Graham number
2.77K8.93K14.87K10.97K631
ROIC
0.060.06-0.0600.09
Return on tangible assets
00.01-0.05-0.030
Graham Net
-11.3K-10.36K-10.53K-9.69K-3.12K
Working capital
136.83B145.54B57.07B64.58B83.77B
Tangible asset value
250.64B244.97B208.7B189.8B167.07B
Net current asset value
51.27B40.23B-8.06B-42.29B-78.06B
Invested capital
0.70.670.820.881.22
Average receivables
00000
Average payables
53.74B46.17B46.49B47.89B49.76B
Average inventory
103.91B101.28B95.82B101.2B101.86B
Days sales outstanding
00000
Days payables outstanding
69.247.7146.9947.2650.64
Days of inventory on hand
123.83108.7894.2699.88100.54
Receivables turnover
00000
Payables turnover
5.277.657.777.727.21
Inventory turnover
2.953.363.873.653.63
ROE
00.03-0.11-0.070
Capex per share
-450.3-343.15-538.52-618.41-122.99

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
6.13K1.61K1.49K1.57K1.61K
Net income per share
209.32-63.9391.099.3478.8
Operating cash flow per share
927.64124.5854.8987.58173.43
Free cash flow per share
794.8684.6518.866.33140.52
Cash per share
2.85K624.11659.84662.590
Book value per share
8.49K1.91K1.93K1.95K2.04K
Tangible book value per share
7.73K1.59K1.62K1.63K1.91K
Share holders equity per share
8.49K1.91K1.93K1.95K2.04K
Interest debt per share
8.86K2.36K2.42K2.34K5.39
Market cap
759.09B3577.34B3982.43B3824.6B3530B
Enterprise value
945.61B3789.12B4201.06B4033.7B3530B
P/E ratio
37.28-132.95103.88973.45106.44
Price to sales ratio
5.0921.1125.4723.1820.78
POCF ratio
33.65272.92689.53415.05193.45
PFCF ratio
39.27401.652.01K548.02238.75
P/B Ratio
3.6817.7819.5818.6616.48
PTB ratio
3.6817.7819.5818.6616.48
EV to sales
6.3522.3626.8724.4520.78
Enterprise value over EBITDA
74.68243.7235.62296.19289.59
EV to operating cash flow
41.92289.08727.39437.74193.45
EV to free cash flow
48.92425.432.12K577.98238.75
Earnings yield
0.010000
Free cash flow yield
0.030000
Debt to equity
0.490.610.750.740
Debt to assets
0.650.70.70.690.68
Net debt to EBITDA
14.7313.6212.2615.350
Current ratio
1.431.31.461.521.22
Interest coverage
4.574.435.643.3920.39
Income quality
4.43-1.950.69.382.2
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.120.160.140.140.34
Research and developement to revenue
0.040.030.040.040
Intangibles to total assets
0.030.030.030.030
Capex to operating cash flow
-0.14-0.32-0.66-0.24-0.19
Capex to revenue
-0.02-0.02-0.02-0.01-0.02
Capex to depreciation
-0.81-1.04-0.81-0.56-0.85
Stock based compensation to revenue
00000
Graham number
6.32K1.66K1.99K639.631.9K
ROIC
0.020.030.030.020.04
Return on tangible assets
0.01-0.010.0200.01
Graham Net
-10.74K-3.11K-3.06K-2.92K-4.02K
Working capital
105.57B83.77B117.4B124.64B74.31B
Tangible asset value
187.89B167.07B170.23B171.8B0
Net current asset value
-32B-78.06B-74.59B-68.51B-7.71B
Invested capital
1.041.221.241.190
Average receivables
00000
Average payables
54.81B55.13B56.49B58.61B0
Average inventory
110.73B107.01B109.29B111.48B0
Days sales outstanding
00000
Days payables outstanding
48.4444.7353.1452.840
Days of inventory on hand
104.4588.8104.7100.510
Receivables turnover
00000
Payables turnover
1.862.011.691.70
Inventory turnover
0.861.010.860.90
ROE
0.02-0.030.0500.04
Capex per share
-132.77-39.93-36.09-21.25-32.91

001065.KS Frequently Asked Questions

What is JW Pharmaceutical Corporation stock symbol ?

JW Pharmaceutical Corporation is a KR stock and trading under the symbol 001065.KS

What is JW Pharmaceutical Corporation stock quote today ?

JW Pharmaceutical Corporation stock price is $32450 today.

Is JW Pharmaceutical Corporation stock public?

Yes, JW Pharmaceutical Corporation is a publicly traded company.

Something similar